Protease Inhibitors

Ritonavir is an antiretroviral (HIV) drug which inhibits a particular liver enzyme that normally metabolizes protease inhibitors, cytochrome P450-3A4 (CYP3A4).Application：Ritonavir has been used:as a human immunodeficiency virus (HIV) protease

Ritonavir is an antiretroviral (HIV) drug which inhibits a particular liver enzyme that normally metabolizes protease inhibitors, cytochrome P450-3A4 (CYP3A4).Application：Ritonavir has been used:as a human immunodeficiency virus (HIV) protease

Ritonavir is an antiretroviral (HIV) drug which inhibits a particular liver enzyme that normally metabolizes protease inhibitors, cytochrome P450-3A4 (CYP3A4).Application：Ritonavir has been used:as a human immunodeficiency virus (HIV) protease

Ritonavir is an antiretroviral (HIV) drug which inhibits a particular liver enzyme that normally metabolizes protease inhibitors, cytochrome P450-3A4 (CYP3A4).Application：Ritonavir has been used:as a human immunodeficiency virus (HIV) protease

Ritonavir is an antiretroviral (HIV) drug which inhibits a particular liver enzyme that normally metabolizes protease inhibitors, cytochrome P450-3A4 (CYP3A4).Application：Ritonavir has been used:as a human immunodeficiency virus (HIV) protease

An HIV protease inhibitor (EC₅₀ = 25 nM) that also inhibits CYP3A4, the primary cytochrome P450 isoform that metabolizes protease inhibitors reduces the metabolism of concomitantly administered protease inhibitiors, enhancing their

An HIV protease inhibitor (EC₅₀ = 25 nM) that also inhibits CYP3A4, the primary cytochrome P450 isoform that metabolizes protease inhibitors reduces the metabolism of concomitantly administered protease inhibitiors, enhancing their

Rosabulin (STA 5312) is a potent and orally active microtubule inhibitor that inhibits microtubule assembly. Rosabulin has broad-spectrum anti-tumor activity.In VitroRosabulin (STA 5312) demonstrates substantial anti-proliferative activity against a

Rosabulin (STA 5312) is a potent and orally active microtubule inhibitor that inhibits microtubule assembly. Rosabulin has broad-spectrum anti-tumor activity.In VitroRosabulin (STA 5312) demonstrates substantial anti-proliferative activity against a

Rosabulin (STA 5312) is a potent and orally active microtubule inhibitor that inhibits microtubule assembly. Rosabulin has broad-spectrum anti-tumor activity.In VitroRosabulin (STA 5312) demonstrates substantial anti-proliferative activity against a

RR-11a analog is a potent and irreversible inhibitor of Schistosoma mansoni legumain , with an IC 50 of 31 nM. RR-11a analog is an aza-Asn derivative and aza-peptide Michael acceptorIn VivoRR-11a analog has a half-live of 3-10 min. MCE has not

RR-11a analog is a potent and irreversible inhibitor of Schistosoma mansoni legumain , with an IC 50 of 31 nM. RR-11a analog is an aza-Asn derivative and aza-peptide Michael acceptorIn VivoRR-11a analog has a half-live of 3-10 min. MCE has not